D
Ironwood Pharmaceuticals, Inc. IRWD
$3.73 $0.236.57% NASDAQ
Recommendation
Prev Close
$3.50
Volume
1,516,492
Avg Vol (90D)
1,898,739
Market Cap
$569.38M
Dividend & Yield
--
52-Week Range
$0.53 - $5.13
P/E (TTM)
23.54
EPS (TTM)
$0.15
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Ironwood Pharmaceuticals (NASDAQ:IRWD) Trading 4.5% Higher - Time to Buy?
12/2/2025 - MarketBeat
Universal Beteiligungs und Servicegesellschaft mbH Buys 108,822 Shares of Ironwood Pharmaceuticals, Inc. $IRWD
11/30/2025 - MarketBeat
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Receives Consensus Rating of "Hold" from Analysts
11/29/2025 - Ticker Report
Ironwood Pharmaceuticals (IRWD, $3.5) RSI Indicator left the overbought zone on November 28, 2025
11/29/2025 - Tickeron - Stocks
Ironwood (IRWD) Skyrockets 23% as Govt Price for Linzess Falls Within Expectations
11/28/2025 - Insider Monkey
IRWD vs. PBYI: Which Small-Cap Biotech Stock Is the Better Pick?
11/27/2025 - Zacks Investment Research
Ironwood Pharmaceuticals (NASDAQ:IRWD) Shares Gap Up - Here's Why
11/27/2025 - MarketBeat
Ironwood Pharmaceuticals (IRWD, $3.86) RSI Indicator left the overbought zone on November 26, 2025
11/27/2025 - Tickeron - Stocks
Ironwood Pharmaceuticals: Today's Gains Seem Sustainable After Disastrous First Half Of 2025
11/26/2025 - Seeking Alpha - Long Ideas
Ironwood Pharmaceuticals: Today's Gains Seem Sustainable After Disastrous First Half Of 2025
11/26/2025 - SeekingAlpha
Ironwood Pharmaceuticals (NASDAQ:IRWD) Shares Down 5.6% - Here's What Happened
11/26/2025 - MarketBeat
Ironwood Pharmaceuticals (IRWD, $3.13) RSI Indicator left the overbought zone on November 25, 2025
11/26/2025 - Tickeron - Stocks
LSV Asset Management Sells 1,247,601 Shares of Ironwood Pharmaceuticals, Inc. $IRWD
11/22/2025 - MarketBeat
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Given Average Recommendation of "Hold" by Brokerages
11/22/2025 - MarketBeat
Commit To Purchase Ironwood Pharmaceuticals At $2, Earn 20.9% Annualized Using Options
11/21/2025 - Stock Options Channel
Can Linzess Continue to Aid IRWD's Top Line After a Strong Q3?
11/21/2025 - Zacks Investment Research
Ironwood Pharmaceuticals, Inc. $IRWD Shares Purchased by Los Angeles Capital Management LLC
11/15/2025 - MarketBeat
Ironwood Pharmaceuticals (IRWD): Evaluating Valuation After Q3 Earnings Beat and Linzess Pediatric Approval
11/14/2025 - Simply Wall St
Research Analysts Offer Predictions for IRWD FY2025 Earnings
11/14/2025 - MarketBeat
Ironwood Pharmaceuticals (NASDAQ:IRWD) Trading Up 9.2% Following Analyst Upgrade
11/13/2025 - MarketBeat
Ironwood Pharmaceuticals (NASDAQ:IRWD) Releases Quarterly Earnings Results, Beats Estimates By $0.15 EPS
11/13/2025 - MarketBeat
IRWD Rises 110% in a Month: Should You Buy, Sell or Hold the Stock?
11/13/2025 - Zacks Investment Research
Leerink Partnrs Analysts Lift Earnings Estimates for IRWD
11/13/2025 - MarketBeat
Ironwood Pharmaceuticals (NASDAQ:IRWD) Shares Up 9.2% Following Analyst Upgrade
11/12/2025 - Ticker Report
Ironwood Pharmaceuticals (NASDAQ:IRWD) Price Target Raised to $3.00
11/12/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
$338.99M
EBITDA (TTM)
$145.68M
EBIT (TTM)
$143.77M
Net Income (TTM)
$28.55M
Balance Sheet
Total Assets (Q)
$396.06M
Total Debt (Q)
$598.24M
Total Liabilities (Q)
$660.22M
Book Value Per Share (Q)
-$1.62
Cash Flow
Cash from Operations (TTM)
$67.68M
Cash from Investing (TTM)
-$35.00K
Cash from Financing (TTM)
-$14.79M
Net Change in Cash (TTM)
$52.20M
Filings
Filing Date
Monday, November 10, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
End of March (est)
Price History
Loading...
Beta
0.49
7-Day Total Return
18.04%
30-Day Total Return
139.10%
60-Day Total Return
236.04%
90-Day Total Return
366.89%
Year to Date Total Return
-13.86%
1-Year Total Return
5.37%
2-Year Total Return
-64.58%
3-Year Total Return
-68.92%
5-Year Total Return
-67.79%
52-week Low
May 16, 2025 - $0.53
52-week High
Dec 20, 2024 - $5.13
Valuation
Market Cap
$569.38M - Small Cap
Enterprise Value
$1.03B
Price/Sales (TTM)
1.84
Price/Book (Q)
-2.16
Dividends and Shares
Shares Outstanding
177.76
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
ironwoodpharma.com
Phone Number
617 621 7722
Address
100 Summer Street
Boston, MA 02110
Country
United States
Year Founded
1998
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Ironwood Pharmaceuticals, Inc., a biotechnology company, focuses on the development and commercialization of therapies for gastrointestinal (GI) and rare diseases in the United States and... more
NASDAQ 12/03/2025 4:00PM Eastern Quotes delayed